Periodic Reporting for period 6 - EBOVAC2 (Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861)

Combining the expertise and capabilities of global research institutions, non-government organizations and the pharmaceutical industry has been critical to help address the Ebola public health challenge. The Ebola vaccine projects - EBOVAC1, EBOVAC2, EBOVAC3, EBODAC and EBOMAN...